Title: Viewpoint: 1 - The future in heart failure management will be driven by biomarkers

Presentor(s)	H. Drexler, Hannover (DE)
Episode	43
Year	2008
Duration	14:37

Shownotes    "Preferably biomarkers should be able to identify patients that have HF, identify his or her risk and monitor treatment effects. BNP has the ability to identify HF, serve as a prognostic marker and can be used to guide therapy. Also serial measurements of Troponin T can identify high risk patients. Novel biomarkers, such as GDF-15, are showing promising results, paving the way for multi-marker strategies."